STS Medical Group was established by Monitor Clipper Partners, a private equity firm based in Boston (Massachusetts) and Augusto Orsini, an executive with over 30 years of experience in the surgical theater solutions market.

In 2022 AEMM biotech capital investment, a family office focusing on long term sustanaible investment, became the major shareholder of STS Medical Group (for more info please visit www.aemmbiotech.com). AEMM biotech capital investments has the ability to provide capital, counsel and support to unlock an enterprise’s full potential, driving long term vision and sustanaibility in a changing world.

STS Medical Group expects to grow through both organic growth and M&A transactions and consolidate its market recognition as the top quality and most transparent player in deliver efficiency to the European health care systems.